Argen X Se Adr (ARGX)

May 22, 2026

Evercore ISI Raises its Price Target on argenx (ARGX) - Yahoo Finance

May 22, 2026

May 20, 2026

Jefferies updates franchise picks list, adding AMZN, APP, MCD and more - MSN

May 20, 2026

May 19, 2026

ARGX.BR Stock Price, Quote & Chart | ARGENX SE (EBR:ARGX) - ChartMill

May 19, 2026

May 18, 2026

argenx SE’s SWOT analysis: stock gains momentum on Vyvgart growth By Investing.com - Investing.com Australia

May 18, 2026

May 18, 2026

Myasthenia Gravis Market Set to Surpass USD 16 Billion by 2036, Fueled by Rising Diagnosed Prevalence and Wave of Targeted Biologic Approvals | DelveInsight - GlobeNewswire Inc.

May 18, 2026

May 18, 2026

argenx SE’s SWOT analysis: stock gains momentum on Vyvgart growth - Investing.com

May 18, 2026

May 15, 2026

argenx SE (ARGX) Stock Price, Trades & News - GuruFocus

May 15, 2026

May 14, 2026

Argenx SE stock (NL0010832176): FMR LLC boosts stake amid price gains - AD HOC NEWS

May 14, 2026

May 13, 2026

Earnings call transcript: Argenx Q1 2026 beats EPS expectations, stock dips - Investing.com

May 13, 2026

May 13, 2026

Is argenx SE (ARGX) Among the Most Promising Biotech Stocks to Buy? - Yahoo Finance

May 13, 2026

May 12, 2026

Argenx Eyes Larger Patient Pool Following Expanded FDA Nod For Lead Drug For Neuromuscular Disease - Sahm

May 12, 2026

May 11, 2026

argenx stock gains after FDA expands MG treatment approval By Investing.com - Investing.com South Africa

May 11, 2026

May 11, 2026

argenx stock gains after FDA expands MG treatment approval - Investing.com

May 11, 2026

May 08, 2026

argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG - ChartMill

May 08, 2026

May 08, 2026

RBC Capital maintains argenx stock price target at $890 on uptake potential - Investing.com Australia

May 08, 2026

May 07, 2026

Earnings call transcript: Argenx beats EPS forecast in Q1 2026 By Investing.com - Investing.com Australia

May 07, 2026

May 07, 2026

Earnings call transcript: Argenx beats EPS forecast in Q1 2026 - Investing.com

May 07, 2026

May 07, 2026

Argenx beats profit forecasts despite revenue miss - Investing.com

May 07, 2026

May 07, 2026

Argenx beats profit forecasts despite revenue miss By Investing.com - Investing.com Canada

May 07, 2026

May 07, 2026

argenx posts 63% revenue growth on strong Vyvgart sales By Investing.com - Investing.com South Africa

May 07, 2026

May 07, 2026

Argenx (ARGX) tops earnings expectations despite slight revenue shortfall - Yahoo Finance

May 07, 2026

May 06, 2026

argenx appoints Karen Massey as CEO, founder moves to chair - Investing.com

May 06, 2026

May 06, 2026

argenx appoints Karen Massey as CEO, founder moves to chair By Investing.com - Investing.com India

May 06, 2026

May 06, 2026

argenx to Present at BofA Securities 2026 Health Care Conference - ChartMill

May 06, 2026

May 06, 2026

argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer - ChartMill

May 06, 2026

May 04, 2026

Here’s Why Argenx SE (ARGX) Slipped in Q1 - Yahoo Finance

May 04, 2026

Apr 30, 2026

ARGX.BR Technical Analysis | Trend, Signals & Chart Patterns | ARGENX SE (EBR:ARGX) - ChartMill

Apr 30, 2026

Apr 30, 2026

argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026 - ChartMill

Apr 30, 2026

Apr 27, 2026

ARGX Stock Price, Quote & Chart | ARGENX SEADR (NASDAQ:ARGX) - ChartMill

Apr 27, 2026

Apr 24, 2026

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Regeneron (REGN) - The Globe and Mail

Apr 24, 2026

Apr 23, 2026

argenx SE Stock Baskets | MEX:ARGXN - GuruFocus

Apr 23, 2026

Apr 23, 2026

argenx SE Stock Operating Data - GuruFocus

Apr 23, 2026

Apr 23, 2026

argenx SE (MEX:ARGXN) Stock News, Headlines & Updates - GuruFocus

Apr 23, 2026

Apr 22, 2026

US-Listed European ADRs Slipped As Drugmakers Weighed On The Tape - Finimize

Apr 22, 2026

Apr 21, 2026

Argenx SE stock (NL0010832176): Is its rare disease focus strong enough to unlock sustained U.S. gro - AD HOC NEWS

Apr 21, 2026

Apr 20, 2026

The Bull Case For argenx (ENXTBR:ARGX) Could Change Following New VYVGART Ocular MG Efficacy Data - Yahoo Finance

Apr 20, 2026

Apr 19, 2026

Argenx SE stock (NL0010832176): Is Vyvgart's momentum strong enough to unlock new upside? - AD HOC NEWS

Apr 19, 2026

Apr 19, 2026

Argenx SE stock (NL0010832176): Is Vyvgart's expansion strong enough to unlock new upside? - AD HOC NEWS

Apr 19, 2026

Apr 19, 2026

Argenx SE stock (NL0010832176): Is Vyvgart's rare disease dominance strong enough to unlock new upsi - AD HOC NEWS

Apr 19, 2026

Apr 18, 2026

Argenx SE stock (NL0010832176): Is Vyvgart's U.S. momentum strong enough to unlock new upside? - AD HOC NEWS

Apr 18, 2026

Apr 18, 2026

argenx SE (MEX:ARGXN) Competitors 2026 - GuruFocus

Apr 18, 2026

Apr 18, 2026

Who's Buying or Selling argenx SE (MEX:ARGXN) Stock Today? - GuruFocus

Apr 18, 2026

Apr 18, 2026

argenx SE (MEX:ARGXN) Stock Price, Trades & News - GuruFocus

Apr 18, 2026

Apr 18, 2026

argenx SE (MEX:ARGXN)Valuation Measures & Financial Statistics - GuruFocus

Apr 18, 2026

Apr 18, 2026

argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP - ChartMill

Apr 18, 2026

Apr 17, 2026

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Avalo Therapeutics (AVTX) - The Globe and Mail

Apr 17, 2026

Apr 14, 2026

Argenx SE stock (NL0010832176): Is Vyvgart's U.S. expansion strong enough to unlock new upside? - AD HOC NEWS

Apr 14, 2026